[{"indications": "Indications\u00a0peripheral and central neuropathic\r\npain (section 4.7.3); adjunctive therapy for focal\r\nseizures with or without secondary generalisation; generalised anxiety\r\ndisorder (section 4.3)", "name": "PREGABALIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Gabapentin and pregabalin"], "cautions": "Cautions\u00a0avoid abrupt withdrawal (taper over at least 1 week); severe congestive heart\r\nfailure; conditions that may precipitate\r\nencephalopathy", "side-effects": "Side-effects\u00a0dry mouth, constipation, vomiting, flatulence,\r\noedema, dizziness, drowsiness, irritability, impaired attention, disturbances\r\nin muscle control and movement, speech disorder, impaired memory,\r\nparaesthesia, euphoria, confusion, malaise, appetite changes, insomnia,\r\nweight gain, sexual dysfunction, visual disturbances (including blurred\r\nvision, diplopia, visual field defects); less commonly abdominal distension, hypersalivation, gastro-oesophageal reflux\r\ndisease, thirst, taste disturbance, flushing, hypotension, hypertension,\r\ntachycardia, syncope, first-degree AV block, dyspnoea, nasal dryness,\r\nstupor, depersonalisation, depression, abnormal dreams, hallucinations,\r\nagitation, cognitive impairment, panic attacks, chills, hypoglycaemia,\r\nthrombocytopenia, urinary incontinence, dysuria, myalgia, arthralgia,\r\ndry eye, lacrimation, hyperacusis, nasopharyngitis, sweating, rash; rarely ascites, dysphagia, pancreatitis, weight loss, cold\r\nextremities, arrhythmia, bradycardia, cough, epistaxis, rhinitis,\r\nparosmia, hyperglycaemia, renal failure, oliguria, menstrual disturbances,\r\nbreast pain, breast discharge, breast hypertrophy, neutropenia, hypokalaemia,\r\nleucopenia, rhabdomyolysis, urticaria; also reported diarrhoea, nausea, congestive heart failure, QT-interval prolongation,\r\naggression, headache, convulsions, encephalopathy, urinary retention,\r\nkeratitis, Stevens-Johnson syndrome, pruritus; suicidal ideation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129077.htm", "doses": ["Neuropathic pain, adult over 18 years, initially 150\u00a0mg daily in 2\u20133 divided doses, increased\r\nif necessary after 3\u20137 days to 300\u00a0mg daily in 2\u20133 divided doses,\r\nincreased further if necessary after 7 days to max. 600\u00a0mg daily in\r\n2\u20133 divided doses", "Epilepsy, adult over 18 years,\r\ninitially 25\u00a0mg twice daily, increased at 7-day intervals in steps\r\nof 50\u00a0mg daily to 300\u00a0mg daily in 2\u20133 divided doses, increased further\r\nif necessary after 7 days to max. 600\u00a0mg daily in 2\u20133 divided doses", "Generalised anxiety disorder, adult over 18 years, initially 150\u00a0mg daily in 2\u20133 divided doses, increased\r\nif necessary at 7-day intervals in steps of 150\u00a0mg daily; max. 600\u00a0mg\r\ndaily in 2\u20133 divided doses", "Pregabalin doses in BNF may differ from those\r\nin product literature"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]